Eva M. Riedmann

1.4k total citations
57 papers, 795 citations indexed

About

Eva M. Riedmann is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Eva M. Riedmann has authored 57 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 12 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Eva M. Riedmann's work include Hepatitis B Virus Studies (8 papers), Influenza Virus Research Studies (6 papers) and Vaccine Coverage and Hesitancy (6 papers). Eva M. Riedmann is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Influenza Virus Research Studies (6 papers) and Vaccine Coverage and Hesitancy (6 papers). Eva M. Riedmann collaborates with scholars based in United States, Austria and Russia. Eva M. Riedmann's co-authors include Werner Lubitz, Michael F. Jantsch, Jochen C. Hartner, Jennelle M. Kyd, Allan W. Cripps, Katri Jalava, Francis O. Eko, Christoph Haller, Gail Hecht and Ulrike Beate Mayr and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Bacteriology and RNA.

In The Last Decade

Eva M. Riedmann

51 papers receiving 765 citations

Peers

Eva M. Riedmann
Eva M. Riedmann
Citations per year, relative to Eva M. Riedmann Eva M. Riedmann (= 1×) peers Francesco Berlanda Scorza

Countries citing papers authored by Eva M. Riedmann

Since Specialization
Citations

This map shows the geographic impact of Eva M. Riedmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva M. Riedmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva M. Riedmann more than expected).

Fields of papers citing papers by Eva M. Riedmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva M. Riedmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva M. Riedmann. The network helps show where Eva M. Riedmann may publish in the future.

Co-authorship network of co-authors of Eva M. Riedmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eva M. Riedmann. A scholar is included among the top collaborators of Eva M. Riedmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva M. Riedmann. Eva M. Riedmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Riedmann, Eva M.. (2014). Human Vaccines & Immunotherapeutics: News. Human Vaccines & Immunotherapeutics. 10(2). 252–255. 4 indexed citations
2.
Riedmann, Eva M.. (2014). Human Vaccines & Immunotherapeutics: News. Human Vaccines & Immunotherapeutics. 10(5). 1139–1142. 11 indexed citations
3.
Riedmann, Eva M.. (2014). Human Vaccines & Immunotherapeutics. Human Vaccines & Immunotherapeutics. 10(8). 2139–2142. 2 indexed citations
4.
Riedmann, Eva M.. (2014). Human Vaccines & Immunotherapeutics: News. Human Vaccines & Immunotherapeutics. 10(6). 1427–1430. 1 indexed citations
5.
Riedmann, Eva M.. (2014). Fingerprint sensors to track vaccination records in developing countries.. PubMed. 10(2). 255–255. 3 indexed citations
6.
Riedmann, Eva M.. (2014). Landes Highlights. RNA Biology. 11(2). 93–94. 1 indexed citations
7.
Riedmann, Eva M.. (2013). Influenza vaccination reduces risk of heart attack and stroke.. PubMed. 9(12). 2500–2500. 3 indexed citations
8.
Riedmann, Eva M.. (2013). Human Vaccines & Immunotherapeutics: News. Human Vaccines & Immunotherapeutics. 9(7). 1395–1398. 2 indexed citations
9.
Riedmann, Eva M.. (2013). Human Vaccines & Immunotherapeutics. Human Vaccines & Immunotherapeutics. 9(10). 2034–2037. 4 indexed citations
10.
Riedmann, Eva M.. (2013). Human Vaccines & Immunotherapeutics: News. Human Vaccines & Immunotherapeutics. 9(12). 2499–2502. 1 indexed citations
11.
Riedmann, Eva M.. (2013). Landes Highlights. RNA Biology. 11(1). 1–2. 2 indexed citations
12.
Riedmann, Eva M.. (2012). News. Human Vaccines & Immunotherapeutics. 8(3). 282–285. 1 indexed citations
13.
Riedmann, Eva M.. (2012). News. Human Vaccines & Immunotherapeutics. 8(2). 151–154. 3 indexed citations
14.
Hecht, Gail & Eva M. Riedmann. (2010). Exciting times for gastrointestinal microbiology. Gut Microbes. 1(1). 1–2. 34 indexed citations
15.
Riedmann, Eva M.. (2010). Only one-third of girls receive HPV vaccine. Human Vaccines. 6(7). 524–527. 1 indexed citations
16.
Riedmann, Eva M., et al.. (2008). Specificity of ADAR-mediated RNA editing in newly identified targets. RNA. 14(6). 1110–1118. 122 indexed citations
17.
Riedmann, Eva M., Jennelle M. Kyd, Allan W. Cripps, & Werner Lubitz. (2007). Bacterial ghosts as adjuvant particles. Expert Review of Vaccines. 6(2). 241–253. 68 indexed citations
18.
Mayr, Ulrike Beate, et al.. (2005). Bacterial ghosts as antigen delivery vehicles. Advanced Drug Delivery Reviews. 57(9). 1381–1391. 99 indexed citations
19.
Jalava, Katri, Francis O. Eko, Eva M. Riedmann, & Werner Lubitz. (2003). Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery. Expert Review of Vaccines. 2(1). 45–51. 70 indexed citations
20.
Riedmann, Eva M., et al.. (2003). Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts â a delivery system for the nontypeableHaemophilus influenzaeantigenOmp26. FEMS Immunology & Medical Microbiology. 37(2-3). 185–192. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026